Mycophenolate Mofetil (MMF)
Treatment for Pyoderma
Typical Dosage: 1-3 g/day, orally
Effectiveness
70%
Safety Score
38%
Clinical Trials
15
Participants
400
Comparative Safety Scale(Higher is safer)
Cyanideβ οΈ
Methπ
Cigarettesπ¬
Chemoβ’οΈ
AlcoholπΊ
Morphineπ
Antibioticsπ
Tylenolπ
Exerciseπ
Waterπ§
38
DangerousModerateSafe
Treatment Details
Dosage Range
1-3 g/day, orally
Time to Effect
4-8 weeks
Treatment Duration
Months to years
Evidence Quality
MODERATEConfidence Score
75%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$500
Monitoring:$750
Side Effect Mgmt:$150
Total Annual:$1,400
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTICER
$2,333.33/QALY
QALYs Gained
0.6
Outcome-Based Costs
Cost per Responder
$2,800
Cost per Remission
$4,666.67
Mycophenolate Mofetil (MMF) Outcomes
for Pyoderma
Efficacy Outcomes
Overall Effectiveness
+70%
Response Rate
+50%
Remission Rate
+30%
Common Side Effects
Diarrhea
+35%
Nausea
+25%
Vomiting
+15%
Leukopenia
+20%
Anemia
+10%
Infections
+10%
Sources:
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov